These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 21297523)
1. Long-term response to GH therapy in short children with a delayed infancy-childhood transition (DICT). Albertsson-Wikland K; Kriström B; Jonsson B; Hochberg Z Pediatr Res; 2011 Jun; 69(6):504-10. PubMed ID: 21297523 [TBL] [Abstract][Full Text] [Related]
2. Dose-dependent effect of growth hormone on final height in children with short stature without growth hormone deficiency. Albertsson-Wikland K; Aronson AS; Gustafsson J; Hagenäs L; Ivarsson SA; Jonsson B; Kriström B; Marcus C; Nilsson KO; Ritzén EM; Tuvemo T; Westphal O; Aman J J Clin Endocrinol Metab; 2008 Nov; 93(11):4342-50. PubMed ID: 18728172 [TBL] [Abstract][Full Text] [Related]
3. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature. Ranke MB; Lindberg A; Price DA; Darendeliler F; Albertsson-Wikland K; Wilton P; Reiter EO; Horm Res; 2007; 68(2):53-62. PubMed ID: 17228181 [TBL] [Abstract][Full Text] [Related]
4. GH treatment and its effect on bone mineral density, bone maturation and growth in short children born small for gestational age: 3-year results of a randomized, controlled GH trial. Arends NJ; Boonstra VH; Mulder PG; Odink RJ; Stokvis-Brantsma WH; Rongen-Westerlaken C; Mulder JC; Delemarre-Van de Waal H; Reeser HM; Jansen M; Waelkens JJ; Hokken-Koelega AC Clin Endocrinol (Oxf); 2003 Dec; 59(6):779-87. PubMed ID: 14974922 [TBL] [Abstract][Full Text] [Related]
5. IGF-1 and growth response to adult height in a randomized GH treatment trial in short non-GH-deficient children. Kriström B; Lundberg E; Jonsson B; Albertsson-Wikland K; J Clin Endocrinol Metab; 2014 Aug; 99(8):2917-24. PubMed ID: 24823461 [TBL] [Abstract][Full Text] [Related]
6. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency. Högler W; Briody J; Moore B; Lu PW; Cowell CT Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578 [TBL] [Abstract][Full Text] [Related]
7. The growth hormone receptor exon 3-deleted/full-length polymorphism and response to growth hormone therapy in prepubertal idiopathic short children. Hellgren G; Glad CA; Jonsson B; Johannsson G; Albertsson-Wikland K Growth Horm IGF Res; 2015 Jun; 25(3):127-35. PubMed ID: 25742716 [TBL] [Abstract][Full Text] [Related]
8. Decreased GH dose after the catch-up growth period maintains metabolic outcome in short prepubertal children with and without classic GH deficiency. Decker R; Albertsson-Wikland K; Kriström B; Halldin M; Dahlgren J Clin Endocrinol (Oxf); 2012 Sep; 77(3):407-15. PubMed ID: 22417085 [TBL] [Abstract][Full Text] [Related]
10. Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial. Willemsen RH; Arends NJ; Bakker-van Waarde WM; Jansen M; van Mil EG; Mulder J; Odink RJ; Reeser M; Rongen-Westerlaken C; Stokvis-Brantsma WH; Waelkens JJ; Hokken-Koelega AC Clin Endocrinol (Oxf); 2007 Oct; 67(4):485-92. PubMed ID: 17561977 [TBL] [Abstract][Full Text] [Related]
11. Cardiac dimension and function in patients with childhood onset growth hormone deficiency, before and after growth hormone retreatment in adult age. Feinberg MS; Scheinowitz M; Laron Z Am Heart J; 2003 Mar; 145(3):549-53. PubMed ID: 12660681 [TBL] [Abstract][Full Text] [Related]
12. Growth hormone responsiveness: peak stimulated growth hormone levels and other variables in idiopathic short stature (ISS): data from the National Cooperative Growth Study. Moore WV; Dana K; Frane J; Lippe B Pediatr Endocrinol Rev; 2008 Sep; 6(1):5-8. PubMed ID: 18806719 [TBL] [Abstract][Full Text] [Related]
13. Growth hormone therapy for children born small for gestational age: height gain is less dose dependent over the long term than over the short term. de Zegher F; Hokken-Koelega A Pediatrics; 2005 Apr; 115(4):e458-62. PubMed ID: 15805349 [TBL] [Abstract][Full Text] [Related]
14. Final height in patients with idiopathic short stature and high growth hormone responses to stimulation tests. Martinelli CE; Sader Milani S; Previato JK; Figueira M; Rangel Montenegro AP; Miraki-Moud F; Betancourth S; Moreira AC; Savage MO; Camacho-Hübner C Horm Res; 2007; 67(5):224-30. PubMed ID: 17135759 [TBL] [Abstract][Full Text] [Related]
15. Growth and growth hormone treatment in short stature children born small for gestational age. Labarta JI; Ruiz JA; Molina I; De Arriba A; Mayayo E; Longás AF Pediatr Endocrinol Rev; 2009 Feb; 6 Suppl 3():350-7. PubMed ID: 19404234 [TBL] [Abstract][Full Text] [Related]
16. Growth hormone (GH) treatment to final height in children with idiopathic short stature: evidence for a dose effect. Wit JM; Rekers-Mombarg LT; Cutler GB; Crowe B; Beck TJ; Roberts K; Gill A; Chaussain JL; Frisch H; Yturriaga R; Attanasio AF J Pediatr; 2005 Jan; 146(1):45-53. PubMed ID: 15644821 [TBL] [Abstract][Full Text] [Related]
17. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age. Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581 [TBL] [Abstract][Full Text] [Related]
19. Bone age progression during the first year of growth hormone therapy in pre-pubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of data from KIGS (Pfizer International Growth Database). Darendeliler F; Ranke MB; Bakker B; Lindberg A; Cowell CT; Albertsson-Wikland K; Reiter EO; Price DA Horm Res; 2005; 63(1):40-7. PubMed ID: 15627781 [TBL] [Abstract][Full Text] [Related]
20. Recombinant human growth hormone plus recombinant human insulin-like growth factor-1 coadministration therapy in short children with low insulin-like growth factor-1 and growth hormone sufficiency: results from a randomized, multicenter, open-label, parallel-group, active treatment-controlled trial. Backeljauw PF; Miller BS; Dutailly P; Houchard A; Lawson E; Hale DE; Reiner B; Sperling MA; Horm Res Paediatr; 2015; 83(4):268-79. PubMed ID: 25765099 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]